Protocolo de seguimiento del tratamiento inmunosupresor en pacientes con enfermedades autoinmunes
- Bohórquez Heras, Cristina
- Movasat, A.
- Cuende Quintana, Eduardo
- Pérez Gómez, A.
ISSN: 0304-5412
Datum der Publikation: 2013
Titel der Ausgabe: Enfermedades del sistema inmune (VI): vasculitis y miopatías inflamatorias
Serie: 11
Nummer: 33
Seiten: 2056-2060
Art: Artikel
Andere Publikationen in: Medicine: Programa de Formación Médica Continuada Acreditado
Ziele für nachhaltige Entwicklung
Zusammenfassung
Once immunosuppressive treatment regimen for a patient with a systemic autoimmune disease, one must be aware of the serious side effects that may occur, and properly monitor each drug. In this protocol were the top immunomodulatory drugs and its most important features, indicating how the proper control of them in monitoring these patients. These drugs have been divided into two major groups, the glucocorticoids, with a significant anti-inflammatory effect but also immunosuppressive and disease modifying drugs, able to change its course through mechanisms not always well known, and to produce a powerful immunosuppression. Each of them has certain peculiarities that must be known.